These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11421258)

  • 1. Cytotoxic cyclolignans related to podophyllotoxin.
    Gordaliza M; Miguel del Corral JM; Angeles Castro M; García-García PA; San Feliciano A
    Farmaco; 2001 Apr; 56(4):297-304. PubMed ID: 11421258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor properties of podophyllotoxin and related compounds.
    Gordaliza M; Castro MA; del Corral JM; Feliciano AS
    Curr Pharm Des; 2000 Dec; 6(18):1811-39. PubMed ID: 11102564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic and antiviral activities of podophyllotoxin related lignans.
    Gordaliza M; Castro MA; García-Grávalos MD; Ruiz P; Miguel del Corral JM; San Feliciano A
    Arch Pharm (Weinheim); 1994 Mar; 327(3):175-9. PubMed ID: 8179476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxicity of podophyllotoxin analogues modified in the A ring.
    Castro A; del Corral JM; Gordaliza M; Grande C; Gómez-Zurita A; García-Grávalos D; San Feliciano A
    Eur J Med Chem; 2003 Jan; 38(1):65-74. PubMed ID: 12593917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of pyrazolignans. A new class of cytotoxic agents.
    Gordaliza M; del Corral JM; Castro MA; López-Vázquez ML; San Feliciano A; García-Grávalos MD; Carpy A
    Bioorg Med Chem; 1995 Sep; 3(9):1203-10. PubMed ID: 8564411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl ethers of podophyllotoxin-related cyclolignans.
    Miguel del Corral JM; Gordaliza M; Castro MA; Morales LJ; Lopez JL; San Feliciano A
    J Nat Prod; 1995 Jun; 58(6):870-7. PubMed ID: 7673931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor.
    Hernández ÁP; Díez P; García PA; Pérez-Andrés M; Ortega P; Jambrina PG; Díez D; Castro MÁ; Fuentes M
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of podophyllotoxins.
    Imbert TF
    Biochimie; 1998 Mar; 80(3):207-22. PubMed ID: 9615861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
    Lv M; Xu H
    Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryltetralin lignans: chemistry, pharmacology and biotransformations.
    Botta B; Delle Monache G; Misiti D; Vitali A; Zappia G
    Curr Med Chem; 2001 Sep; 8(11):1363-81. PubMed ID: 11562272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
    Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
    Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of podophyllotoxin congeners as potential DNA topoisomerase II inhibitors.
    Kamal A; Atchison K; Daneshtalab M; Micetich RG
    Anticancer Drug Des; 1995 Oct; 10(7):545-54. PubMed ID: 7495478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyltrioxorhenium catalysed synthesis of highly oxidised aryltetralin lignans with anti-topoisomerase II and apoptogenic activities.
    Saladino R; Fiani C; Belfiore MC; Gualandi G; Penna S; Mosesso P
    Bioorg Med Chem; 2005 Nov; 13(21):5949-60. PubMed ID: 16112581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection methodology with scoring system: application to Mexican plants producing podophyllotoxin related lignans.
    Lautié E; Quintero R; Fliniaux MA; Villarreal ML
    J Ethnopharmacol; 2008 Dec; 120(3):402-12. PubMed ID: 18930796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
    Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
    J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive constituents from roots of Bursera tonkinensis.
    Jutiviboonsuk A; Zhang H; Tan GT; Ma C; Van Hung N; Manh Cuong N; Bunyapraphatsara N; Soejarto DD; Fong HH
    Phytochemistry; 2005 Dec; 66(23):2745-51. PubMed ID: 16289147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
    Pettit GR; Searcy JD; Tan R; Cragg GM; Melody N; Knight JC; Chapuis JC
    J Nat Prod; 2016 Mar; 79(3):507-18. PubMed ID: 26938998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lignopurines: a new family of hybrids between cyclolignans and purines. Synthesis and biological evaluation.
    Castro MÁ; Miguel del Corral JM; García PA; Rojo MV; Bento AC; Mollinedo F; Francesch AM; San Feliciano A
    Eur J Med Chem; 2012 Dec; 58():377-89. PubMed ID: 23153810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor agents. 100. Inhibition of human DNA topoisomerase II by cytotoxic ether and ester derivatives of podophyllotoxin and alpha-peltatin.
    Thurston LS; Imakura Y; Haruna M; Li DH; Liu ZC; Liu SY; Cheng YC; Lee KH
    J Med Chem; 1989 Mar; 32(3):604-8. PubMed ID: 2537424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
    Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
    Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.